Frederick C. Kull

3.5k total citations · 1 hit paper
39 papers, 2.7k citations indexed

About

Frederick C. Kull is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Frederick C. Kull has authored 39 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Frederick C. Kull's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Neuropeptides and Animal Physiology (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Frederick C. Kull is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Neuropeptides and Animal Physiology (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Frederick C. Kull collaborates with scholars based in United States, Netherlands and India. Frederick C. Kull's co-authors include Pedro Cuatrecasas, Steven Jacobs, Judson J. Van Wyk, Steven Jacobs, Y F Su, H. Shelton Earp, Julie B. Stimmel, Shalender Bhasin, Wayne E. Taylor and M Azam and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Frederick C. Kull

37 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monoclonal antibodies to receptors for insulin and somatomedin-C.

1983 383 citations Frederick C. Kull, Steven Jacobs et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederick C. Kull United States	20	1.8k	846	404	404	353	39	2.7k
Susan S. Leong United States	16	1.4k 0.8×	392 0.5×	627 1.6×	307 0.8×	229 0.6×	26	2.9k
Sergei M. Danilov United States	36	1.7k 1.0×	469 0.6×	391 1.0×	313 0.8×	603 1.7×	123	3.7k
H. Gregory United Kingdom	32	1.8k 1.1×	428 0.5×	820 2.0×	232 0.6×	310 0.9×	64	3.9k
C. Richard Savage United States	20	1.8k 1.0×	258 0.3×	603 1.5×	182 0.5×	516 1.5×	39	2.9k
Lilli Petruzzelli United States	20	3.0k 1.7×	680 0.8×	689 1.7×	696 1.7×	460 1.3×	28	4.6k
Sachiya Ohtaki Japan	28	839 0.5×	919 1.1×	306 0.8×	467 1.2×	162 0.5×	99	2.3k
Helmut J. Kolb Germany	28	1.3k 0.8×	792 0.9×	273 0.7×	157 0.4×	65 0.2×	71	2.8k
Alberto Abbruzzese Italy	36	1.3k 0.8×	354 0.4×	1.1k 2.6×	393 1.0×	234 0.7×	82	3.3k
Mark J. Evans United States	32	1.5k 0.9×	233 0.3×	702 1.7×	527 1.3×	169 0.5×	79	3.2k
Bunzo Sato Japan	25	1.2k 0.7×	633 0.7×	265 0.7×	144 0.4×	83 0.2×	114	2.3k

Countries citing papers authored by Frederick C. Kull

Since Specialization

Citations

This map shows the geographic impact of Frederick C. Kull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick C. Kull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick C. Kull more than expected).

Fields of papers citing papers by Frederick C. Kull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick C. Kull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick C. Kull. The network helps show where Frederick C. Kull may publish in the future.

Co-authorship network of co-authors of Frederick C. Kull

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick C. Kull. A scholar is included among the top collaborators of Frederick C. Kull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick C. Kull. Frederick C. Kull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aiyar, Nambi, Zhaohui Ao, Jyoti Disa, et al.. (2004). Differential levels of “urotensin-II-like” activity determined by radio-receptor and radioimmuno-assays. Peptides. 25(8). 1339–1347. 17 indexed citations

Su, Jui‐Lan, Susan M. Goldsworthy, Chris Plumpton, et al.. (2004). A cell-based time-resolved fluorescence assay for selection of antibody reagents for G protein-coupled receptor immunohistochemistry. Journal of Immunological Methods. 291(1-2). 123–135. 8 indexed citations

Su, Jui‐Lan, Zhaohui Ao, Nambi Aiyar, et al.. (2003). Production and Characterization of Monoclonal Antibodies against the Vasoconstrictive Peptide Human Urotensin-II. PubMed. 22(6). 377–382. 5 indexed citations

Taylor, Wayne E., Shalender Bhasin, Jorge Artaza, et al.. (2001). Myostatin inhibits cell proliferation and protein synthesis in C₂C₁₂ muscle cells. American Journal of Physiology-Endocrinology and Metabolism. 280(2). E221–E228. 342 indexed citations

Stimmel, Julie B., B M Merrill, Lee F. Kuyper, et al.. (2000). Site-specific Conjugation on Serine → Cysteine Variant Monoclonal Antibodies. Journal of Biological Chemistry. 275(39). 30445–30450. 55 indexed citations

Bynum, Jane M., et al.. (1999). Development of Class-Switched, Affinity-Matured Monoclonal Antibodies Following a 7-Day Immunization Schedule. Hybridoma. 18(5). 407–411. 11 indexed citations

Zia, Farah, et al.. (1996). Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo. Journal of Cellular Biochemistry. 63(S24). 269–275. 42 indexed citations

Stimmel, Julie B., et al.. (1995). Yttrium-90 Chelation Properties of Tetraazatetraacetic Acid Macrocycles, Diethylenetriaminepentaacetic Acid Analogs, and a Novel Terpyridine Acyclic Chelator. Bioconjugate Chemistry. 6(2). 219–225. 43 indexed citations

Leban, Johann, Antonio Landavazo, John D. McDermed, et al.. (1994). Potent Gastrin-Releasing Peptide (GRP) Antagonists Derived from GRP(19-27) with a C-Terminal DPro.PSI.[CH2NH]Phe-NH2 and N-Terminal Aromatic Residues. Journal of Medicinal Chemistry. 37(4). 439–445. 12 indexed citations

10.

Singh, Pomila, et al.. (1992). A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo. Regulatory Peptides. 40(1). 75–86. 16 indexed citations

11.

Kull, Frederick C., et al.. (1990). Drug‐induced alterations of tumor necrosis factor‐mediated cytotoxicity: Discrimination of early versus late stage action. Journal of Cellular Biochemistry. 42(1). 1–12. 17 indexed citations

12.

Klitzman, Bruce, et al.. (1989). The effect of nicotinamide on microvascular density and thermal injury in rats. Journal of Surgical Research. 47(5). 465–469. 13 indexed citations

13.

Arteaga, Carlos L., Ester B. Coronado, Steven Jacobs, et al.. (1989). Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.. Journal of Clinical Investigation. 84(5). 1418–1423. 279 indexed citations

14.

Kull, Frederick C.. (1988). Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoids. Biochemical and Biophysical Research Communications. 153(1). 402–409. 39 indexed citations

15.

Adams, David J., et al.. (1987). An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochemical and Biophysical Research Communications. 149(1). 276–281. 141 indexed citations

16.

Jacobs, Steven, Frederick C. Kull, & Pedro Cuatrecasas. (1983). Monensin blocks the maturation of receptors for insulin and somatomedin C: Identification of receptor precursors. Proceedings of the National Academy of Sciences. 80(5). 1228–1231. 118 indexed citations

17.

Kull, Frederick C. & Pedro Cuatrecasas. (1981). Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum.. The Journal of Immunology. 126(4). 1279–1283. 77 indexed citations

18.

Kull, Frederick C., et al.. (1961). Mixtures of Quaternary Ammonium Compounds and Long-chain Fatty Acids as Antifungal Agents. Applied Microbiology. 9(6). 538–541. 18 indexed citations

19.

Kull, Frederick C., et al.. (1954). Inhibition of Melanin Formation In vivo by 4-Chlororesorcinol. Experimental Biology and Medicine. 87(3). 538–540. 9 indexed citations

20.

Mayer, Rudolf, et al.. (1953). Role of Lipids in Formation of Yellow Pigment from p-Aminobenzoic and p-Aminosalicylic Acids. Experimental Biology and Medicine. 83(2). 378–383. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact